Investigating the Mechanisms of Cancer Metastasis through Novel In Vitro and In Vivo Models
Abstract
Cancer is the second highest cause of death globally. In an estimated 90% of all cases, the spread of cancer cells from the initial tumor to a distant site—aka metastasis—is the primary cause of death. Efforts to develop a metastasis-targeting therapy have been faced with frequent failure in clinical trials despite strong preclinical evidence. This discrepancy is largely the result of inadequate models for capturing the complexities of metastasis. In this thesis work, two novel platforms for evaluating metastatic disease were developed. In one platform, progressively invasive subpopulations of metastatic breast cancer were isolated using xenografted zebrafish embryos and characterized to identify two candidate gene targets whose knockdown can significantly reduce invasive spread. In the other platform, circulating tumor cell (CTC) isolation from whole blood based on cell density produced consistent and robust patient-derived CTC cultures and CTC-derived xenografts (CDXs) in immunocompromised mice. For a subset of these cultures and CDXs, transcriptomic and mutational profiling provided insight into possible metastasis biomarkers. Together, this work provides evidence highlighting potential drivers—both previously known as well as new candidates—of cancer metastasis. In the future, these platforms could be critical to the development of metastasis-targeting therapies as robust models of patient-derived metastasis in personalized medicine.
Description
Ph.D.
Permanent Link
http://hdl.handle.net/10822/1064764Date Published
2022Subject
Type
Publisher
Georgetown University
Extent
165 leaves
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Mechanisms of epithelial cell cancer generation: genetic risk factors on cancer progression investigated using in vivo models and at a single cell level
Nakles, Rebecca Elizabeth (Georgetown University, 2012)Loss of Brca1, loss of p53, AIB1/AIB1delta3 over-expression, and ERalpha; over-expression, are risk factors for breast cancer development. These risk factors influence on mammary gland development and breast cancer risk ...